178 related articles for article (PubMed ID: 9024169)
1. Triazolam is ineffective in patients taking rifampin.
Villikka K; Kivistö KT; Backman JT; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Jan; 61(1):8-14. PubMed ID: 9024169
[TBL] [Abstract][Full Text] [Related]
2. Rifampin drastically reduces plasma concentrations and effects of oral midazolam.
Backman JT; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1996 Jan; 59(1):7-13. PubMed ID: 8549036
[TBL] [Abstract][Full Text] [Related]
3. Rifampin reduces plasma concentrations and effects of zolpidem.
Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
[TBL] [Abstract][Full Text] [Related]
4. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
[TBL] [Abstract][Full Text] [Related]
5. Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin.
Kivistö KT; Villikka K; Nyman L; Anttila M; Neuvonen PJ
Clin Pharmacol Ther; 1998 Dec; 64(6):648-54. PubMed ID: 9871429
[TBL] [Abstract][Full Text] [Related]
6. Enhanced effect of triazolam with diltiazem.
Kosuge K; Nishimoto M; Kimura M; Umemura K; Nakashima M; Ohashi K
Br J Clin Pharmacol; 1997 Apr; 43(4):367-72. PubMed ID: 9146848
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the cytochrome P450-mediated metabolism of ifosfamide by ketoconazole and rifampin.
Kerbusch T; Jansen RL; Mathôt RA; Huitema AD; Jansen M; van Rijswijk RE; Beijnen JH
Clin Pharmacol Ther; 2001 Aug; 70(2):132-41. PubMed ID: 11503007
[TBL] [Abstract][Full Text] [Related]
8. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
[TBL] [Abstract][Full Text] [Related]
9. Diltiazem enhances the effects of triazolam by inhibiting its metabolism.
Varhe A; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1996 Apr; 59(4):369-75. PubMed ID: 8612379
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
Varhe A; Olkkola KT; Neuvonen PJ
Br J Clin Pharmacol; 1996 Apr; 41(4):319-23. PubMed ID: 8730978
[TBL] [Abstract][Full Text] [Related]
11. CYP3A inductive potential of the rifamycins, rifabutin and rifampin, in the rabbit.
Weber A; Kaplan M; Chughtai SA; Cohn LA; Smith AL; Unadkat JD
Biopharm Drug Dispos; 2001 May; 22(4):157-68. PubMed ID: 11745918
[TBL] [Abstract][Full Text] [Related]
12. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo.
Villikka K; Varis T; Backman JT; Neuvonen PJ; Kivistö KT
Eur J Clin Pharmacol; 2001 Sep; 57(6-7):457-60. PubMed ID: 11699609
[TBL] [Abstract][Full Text] [Related]
13. Concentrations and effects of zopiclone are greatly reduced by rifampicin.
Villikka K; Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
Br J Clin Pharmacol; 1997 May; 43(5):471-4. PubMed ID: 9159561
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
[TBL] [Abstract][Full Text] [Related]
15. Effect of modafinil on the pharmacokinetics of ethinyl estradiol and triazolam in healthy volunteers.
Robertson P; Hellriegel ET; Arora S; Nelson M
Clin Pharmacol Ther; 2002 Jan; 71(1):46-56. PubMed ID: 11823757
[TBL] [Abstract][Full Text] [Related]
16. Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations.
Kyrklund C; Backman JT; Kivistö KT; Neuvonen M; Laitila J; Neuvonen PJ
Clin Pharmacol Ther; 2000 Dec; 68(6):592-7. PubMed ID: 11180018
[TBL] [Abstract][Full Text] [Related]
17. Lack of interaction between citalopram and the CYP3A4 substrate triazolam.
Nolting A; Abramowitz W
Pharmacotherapy; 2000 Jul; 20(7):750-5. PubMed ID: 10907965
[TBL] [Abstract][Full Text] [Related]
18. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
[TBL] [Abstract][Full Text] [Related]
19. The effect of dexamethasone on the pharmacokinetics of triazolam.
Villikka K; Kivistö KT; Neuvonen PJ
Pharmacol Toxicol; 1998 Sep; 83(3):135-8. PubMed ID: 9783333
[TBL] [Abstract][Full Text] [Related]
20. The effect of rifampin on the pharmacokinetics of oral and intravenous ondansetron.
Villikka K; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1999 Apr; 65(4):377-81. PubMed ID: 10223773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
